Twist Bioscience Corp (TWST) stock
TWSTNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends September 30
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-K on Nov 16, 2026Score 13/30231% above fair value
$112.00+6.96 (+6.63%)
Close on Nov 17, 2026Market cap $7.02BP/E –Yield –
Twist Bioscience enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Twist Bioscience's enterprise value was $7.52B on Nov 11, 2026, against $1.71B a year earlier. Over the last 5 years it ranged from $268.22M to $11.94B, with a median of $1.88B.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $7.52B | +344.5% |
| 2025 | Dec 31, 2025 | $1.69B | -31.2% |
| 2024 | Dec 31, 2024 | $2.46B | +37.6% |
| 2023 | Dec 29, 2023 | $1.79B | +112.3% |
| 2022 | Dec 30, 2022 | $840.84M | -74.9% |
| 2021 | Dec 31, 2021 | $3.35B | -44.9% |
| 2020 | Dec 31, 2020 | $6.08B | +986.6% |
| 2019 | Dec 31, 2019 | $559.96M | +18636.2% |
| 2018 | Dec 31, 2018 | $2.99M | – |
See a number that looks wrong?